
See exactly how VOT's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for VOT and 80,000+ other tickers.
This ETF is designed to mirror the investment returns of the CRSP US Mid Cap Growth Index, an index that gauges the performance of mid-sized companies with strong growth characteristics. It provides investors with a straightforward means to replicate the financial outcomes of a varied collection of growing, medium-sized enterprises. The fund adheres to a passively managed, full-replication strategy, seeking to hold all securities within its benchmark index.

Artificial intelligence has been one of the market's most powerful investment themes over the past several years, helping propel the so-called Magnificent Seven stocks to enormous gains.

Launched on August 17, 2006, the Vanguard Mid-Cap Growth Index Fund ETF Shares (VOT) is a passively managed exchange traded fund designed to provide a broad exposure to the Mid Cap Growth segment of the US equity market.

If you're interested in broad exposure to the Mid Cap Growth segment of the US equity market, look no further than the Vanguard Mid-Cap Growth Index Fund ETF Shares (VOT), a passively managed exchange traded fund launched on August 17, 2006.

Brindle and Bay Financial Advisors LLC acquired a new position in shares of Vanguard Mid-Cap Growth ETF (NYSEARCA:VOT) during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 7,287 shares of the company's stock, valued at approximately $2,034,000. Vanguard Mid-Cap Growth

Vanguard Mid-Cap Growth Index Fund ETF (VOT) is downgraded to hold due to underperformance versus core mid-cap peers and lofty valuations. VOT trades at a 35x trailing PE, higher than both core mid-cap and large-cap growth ETFs, limiting upside amid investor rotation to mid-caps. The fund's portfolio structure, with less industrials and struggling upper-mid-cap tech and health care stocks, further weighs on returns.